Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis.
about
Strategies for managing sexual dysfunction induced by antidepressant medicationModifying Risk Factors in the Management of Erectile Dysfunction: A ReviewVilazodone for the Treatment of Depression: An UpdatePharmacology of serotonin and female sexual behaviorEfficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized-controlled trials comparison with venlafaxineGetting personal: a review of sexual functioning, body image, and their impact on quality of life in patients with inflammatory bowel diseaseAntidepressant efficacy of agomelatine: meta-analysis of published and unpublished studiesEfficacy of agomelatine in major depressive disorder: meta-analysis and appraisalEffects of the triple reuptake inhibitor amitifadine on extracellular levels of monoamines in rat brain regions and on locomotor activityPharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next DecadeAntidepressants and the Placebo EffectThe efficacy of paroxetine and placebo in treating anxiety and depression: a meta-analysis of change on the Hamilton Rating ScalesSexual Functioning in Adolescents With Major Depressive Disorder.Depression in primary care: Strategies for a psychiatry-scarce environment.Treatment-emergent sexual dysfunction in randomized trials of vortioxetine for major depressive disorder or generalized anxiety disorder: a pooled analysis.Antidepressants and sexual dysfunction: mechanisms and clinical implications.Sexual dysfunction associated with major depressive disorder and antidepressant treatment.Neural correlates of antidepressant-related sexual dysfunction: a placebo-controlled fMRI study on healthy males under subchronic paroxetine and bupropionHow does this happen? Part I: mechanisms of adverse drug reactions associated with psychotropic medications.Change in symptoms of erectile dysfunction in depressed men initiating buprenorphine therapy.Exercise improves sexual function in women taking antidepressants: results from a randomized crossover trialA comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?Continuation treatment of major depressive disorder: is there a case for duloxetine?Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder.Sexual function in women on estradiol or venlafaxine for hot flushes: a randomized controlled trial.No association between COMT val158met polymorphism and suicidal behavior: meta-analysis and new data.The efficacy and tolerability of bupropion in the treatment of major depressive disorder.Pharmacogenomic study of side-effects for antidepressant treatment options in STAR*D.Treatment-emergent sexual dysfunction with SSRIs and duloxetine: effectiveness and functional outcomes over a 6-month observational period.Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause.Significant resolution of female sexual dysfunction after bariatric surgery.Bupropion for the treatment of seasonal affective disorder.Levomilnacipran for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant--what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?Reversal of SSRI-induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double-blind, placebo-controlled and randomized study.Comparative efficacy of escitalopram in the treatment of major depressive disorder.Differential effects of vilazodone versus citalopram and paroxetine on sexual behaviors and serotonin transporter and receptors in male rats.Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-analysis.Rosa damascena oil improves SSRI-induced sexual dysfunction in male patients suffering from major depressive disorders: results from a double-blind, randomized, and placebo-controlled clinical trial.Association of TPH-1 and TPH-2 gene polymorphisms with suicidal behavior: a systematic review and meta-analysisDepression sum-scores don't add up: why analyzing specific depression symptoms is essential
P2860
Q24202675-A038FB75-9E40-4734-B7F6-D4F2D482A148Q26737722-E770EC01-2224-4595-ADAE-AB62D20DC381Q26745605-054C1968-5985-4D70-B24B-21BCEDDFA565Q26861672-43A92D05-2FAB-4172-BC30-A66CE2C82A00Q26864531-189844B6-9F29-4767-A0EE-1A976FB61EFBQ28081954-ADF97E36-8230-4743-A623-9BD3769E46B7Q28236293-D65C1C0A-9CC2-4AAB-9DF0-542277091B15Q28246147-20C22282-EEF4-4209-B777-028AD9103847Q28256557-57832324-67F2-456F-80FB-EE8B1E2AEAC6Q28392069-1BA2FC50-3A83-4DE4-BB5A-273C28E9F765Q28468667-9E75CAC1-5772-4946-9DA2-98D1BC529F12Q28542596-9C4BD866-8769-47B9-AB4D-60DA9ECAB462Q30276263-0E0B7BAB-CFEE-49F4-A721-17BBA543427AQ30276979-A80DCE1B-B413-49AB-94F9-C6A27F5BA23FQ30278078-FB9CA8AC-850F-46FC-9BE7-C8C98B87E31BQ30457744-A5100880-6CF9-4740-BB13-F4781EB706C7Q30458935-916869BE-40C5-40AF-8F72-DD9742474F4CQ30503382-C30690F6-08D3-444C-B9FD-0B67E399B269Q33602939-EBD2FE33-3DD2-456A-9997-0ED0D86E98ECQ33609392-D726D452-2179-423F-8F2F-16D76420CC5FQ33690148-1A499B56-22D2-4F13-A51F-D6417A8BC8A1Q33718185-CF575A13-0626-42F6-839D-C6786BD9B99DQ33755767-976FAE67-9D78-4684-A24E-A140F841A738Q33933912-B82D9119-12D3-42DE-B557-71EA5F9EE7E3Q33964099-00DA025F-5C26-4B25-9C77-79DEC593A0F6Q34026890-B8CCBCC2-BEE8-4138-9ED7-594934B371D0Q34226014-9DD45925-288B-4AE7-9CA6-E1633DEADE84Q34229109-31641B76-1DF7-4C75-B6F3-5F813363AFDDQ34236311-73F44FB1-822F-4663-949B-2C2360B71C94Q34243328-58717884-0411-487A-9CFA-42B7E29E4027Q34279788-1E97A1E1-7DDE-4184-AB1D-15DA411E364DQ34346558-F3EA678D-D3A3-48C9-9712-452F2B6065F1Q34369664-819F58C9-2054-437B-81FA-1F22D0462AA4Q34659646-3DF43626-78FB-47DB-AEFF-192515D2242FQ34664591-F5CF08D3-5F7D-4557-B332-7B7500721A6CQ34675188-0F559043-D29F-488F-A85B-6FE7505F1100Q35066804-C638DBDD-8DAF-4AF3-AEA4-75F58D8C5818Q35174211-A3591CD6-780A-4489-8C8B-BEE6326669F4Q35203432-9D45E57A-D30F-4C3C-BBE3-CD7EA92D6389Q35276531-733320A7-36BC-4D38-9C97-9FBC7A65C5BC
P2860
Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis.
@ast
Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis.
@en
Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis.
@nl
type
label
Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis.
@ast
Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis.
@en
Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis.
@nl
prefLabel
Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis.
@ast
Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis.
@en
Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis.
@nl
P1476
Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis.
@en
P2093
Alberto Chiesa
P304
P356
10.1097/JCP.0B013E3181A5233F
P407
P577
2009-06-01T00:00:00Z